Trial reportEuropean journal of nutrition2025
Fava bean and buckwheat are sustainable food sources which support satiety and beneficially modulate several biomarkers, bacteria and metabolites associated with human health.
Trial report in European journal of nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07513610 (The Effects of Dietary Quinoa and Buckwheat Consumption on Weight Management and Gut Microbiome), which is not on this map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Effects of Dietary Quinoa and Buckwheat Consumption on Weight Management and Gut Microbiome
Who cites it
3 citing papers in PubMed.
- Gut Microbiome-Associated Effects of Plant-Based Diets on Glucose Homeostasis, Body Composition, and Cognitive Function: A Scoping Review.Advances in nutrition (Bethesda, Md.) · 2026Article
- Buckwheat Flavonoids Modulate Inflammation in RAW 264.7 Macrophages at Physiologically Relevant Concentrations via the LPS/COX-2 Pathway.Journal of agricultural and food chemistry · 2026Article
- Plant-based dietary biomarkers: from discovery to validation using mass spectrometry-based metabolomics.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundThe world's population requires adequate food supply, satisfying specific nutrient requirements to meet dietary recommendations, promote nutrition security and sustain health, while stimulating agriculture biodiversity. This study assessed the potential of buckwheat and fava bean to diversify the source of dietary nutrients.
methodsTwenty healthy volunteers (n = 6 men, n = 14 women; 42.08 ± 12.12 years; body mass index 24.72 ± 4.69 kg/m
resultsBoth intervention diets were as satiating as the volunteers' habitual diets (p = 0.234). The fava bean diet significantly reduced fasted plasma glucose and insulin and increased plasma homocysteine (p < 0.05). Buckwheat diet decreased plasma homocysteine (p < 0.01) and increased plasma, urine and faecal concentrations of salicylic acid and 2,3-dihydroxybenzoic acid. Both diets significantly increased plasma non-esterified fatty acids values, reduced plasma urea and faecal deoxycholic acid concentrations (p < 0.05). The fava bean diet provided significantly higher amounts of dietary fibre (both in comparison with habitual and buckwheat diet) significantly increasing the urine indole-3-propionic acid concentration (p < 0.01) (Day 0 vs. Day 7) and the faecal, plasma and urine indole-3-propionic acid concentrations (p < 0.01) (on Day 7 buckwheat vs. Day 7 fava bean diet). Furthermore, the fava bean diet promoted the growth of the gut bacterium Coprococcus eutactus (p < 0.05).
conclusionBuckwheat and fava bean contribute in a sustainable way to meet dietary recommendations and to promote dietary diversification. Diets rich in buckwheat and fava bean were found to be satiating and to beneficially modulate several biomarkers, bacteria and metabolites which are correlated with prevention of metabolic disorders such as cardiovascular disease and type 2 diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.